Representative, quality, timely and continuous genetic surveillance of SARS-CoV-2 is critical to the COVID-19 outbreak response. This document provides practical guidance to Global Influenza Surveillance and Response System (GISRS) laboratories and other relevant national laboratories to move beyond virus detection to genomic sequencing of SARS-CoV-2 PCR positive materials obtained from sentinel surveillance of influenza-like illness (ILI), acute respiratory infection (ARI) and severe acute respiratory infection (SARI). It contains considerations on sample selection for sequencing, numbers of viruses to be sequenced, metadata and timeliness for sharing genetic sequence data (GSD) and opportunities for technical support.

Obsahuje bibliografické odkazy

000      

00000nam a2200000 i 4500

001      

MED00206366

003      

CZ-PrNML

005      

20210226182322.0

008      

210225s2021 sz eo 000 0|eng||

009      

W

040    __

$a ABA008 $b cze $d ABA008 $e rda

041    0_

$a eng

044    __

$a sz

072    _7

$a 614 $x Veřejné zdraví a hygiena $2 Konspekt $9 14 $7 sk136314

110    2_

$a Světová zdravotnická organizace $7 kn20010711442

245    10

$a Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2 : $b 16 February 2021

264    _1

$a [Geneva] : $b World Health Organization, $c [2021]

264    _4

$c ©2021

300    __

$a iii, 6 stran

336    __

$a text $b txt $2 rdacontent

337    __

$a počítač $b c $2 rdamedia

338    __

$a online zdroj $b cr $2 rdacarrier

347    __

$a textový soubor $b PDF $2 rda

504    __

$a Obsahuje bibliografické odkazy

520    3_

$a Representative, quality, timely and continuous genetic surveillance of SARS-CoV-2 is critical to the COVID-19 outbreak response. This document provides practical guidance to Global Influenza Surveillance and Response System (GISRS) laboratories and other relevant national laboratories to move beyond virus detection to genomic sequencing of SARS-CoV-2 PCR positive materials obtained from sentinel surveillance of influenza-like illness (ILI), acute respiratory infection (ARI) and severe acute respiratory infection (SARI). It contains considerations on sample selection for sequencing, numbers of viruses to be sequenced, metadata and timeliness for sharing genetic sequence data (GSD) and opportunities for technical support.

650    _7

$a veřejné zdravotnictví $7 nlk20040148357 $2 mednas

650    _7

$a COVID-19 $7 D000086382 $2 czmesh

650    _7

$a Betacoronavirus $7 D000073640 $2 czmesh

650    _7

$a epidemický výskyt choroby $7 D004196 $2 czmesh

650    _7

$a ochrana veřejného zdraví $7 D062486 $2 czmesh

650    _7

$a epidemiologické monitorování $7 D062665 $2 czmesh

650    _7

$a sekvenování celého genomu $7 D000073336 $2 czmesh

655    _4

$a publikace WHO $7 nlk20040156070

856    41

$u https://www.who.int/publications/i/item/WHO-2019-nCoV-genomic-sequencing-GISRS-2021.1 $y plný text volně přístupný

910    __

$a ABA008 $b online $y 0

990    __

$a 20210225181012 $b ABA008

991    __

$a 20210226182322 $b ABA008

999    __

$a ok $b medvik21 $g 1625260 $s 222281

LZP    __

$b 2016online